Rubicon Research Limited (RUBICON)
General Updates
AI summary
- Q2 FY27 revenue grew 40% y-y to INR577 Cr; EBITDA INR146 Cr, PAT INR90 Cr
- H1 FY27 revenue INR1,111 Cr (+45% y-y); PAT INR175 Cr (+80% y-y)
- Operating EBITDA margin guided at 24%+ for full FY27
- Three manufacturing sites pre-revenue; Pithampur to start FY28; others timeline uncertain
- R&D spend steady at ~10.8% of revenue; productivity improving with 5.8x revenue growth impact
- Regulatory inspections recent; observations procedural, no data integrity issues
- Arinna acquisition included; focus on growth before margin improvement
- Sequential USD revenue growth 5% in Q2; specialty products drive stable pricing and gross profit
- Multiple analyst queries on R&D efficiency and manufacturing site commissioning timelines
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 RUBICON — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add RUBICON to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Rubicon Research Limited
Important.
The summary above is generated automatically from Rubicon Research Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.